The NIAID Genomic Centers for Infectious Diseases (GCID) provide insights into the biology of microbes, their role in pathogenesis, and their interactions with the host, including the microbiome, by supporting a diverse set of genomic capabilities, such as high-throughput sequencing and related genomic technologies.
Main Areas of Focus
- Develop and use high-throughput sequencing and related genomic technologies such as transcriptomics and metagenomics of microorganisms, vectors, hosts and host microbiomes to address knowledge gaps
- Develop comparative genomic analysis tools for genotyping and variant identification as well as phylogeny inference
- Implement and improve gene expression techniques for pathogenic microorganisms to understand pathogen and gene functions
- Provide bioinformatics software tools, analyses, methods and protocols to the scientific community
- Provide sequencing, technology, and bioinformatic infrastructure to address and respond to pathogen outbreaks
GCID Award Information
The Center for Advancing Genomic, Transcriptomic and Functional Approaches to Combat Globally Important and Emerging Pathogens
Principal Investigator/Director: Daniel Neafsey, Ph.D.
Institute: Broad Institute, Boston, Massachusetts
The Center for Integrated Genomics of Mucosal Infections
Principal Investigator/Director: Joseph Petrosino, Ph.D.
Institute: Baylor College of Medicine, Houston, Texas
The Michigan Infectious Disease Genomics (MIDGE) Center
Principal Investigator/Director: Adam Lauring, Ph.D.
Institute: The University of Michigan, Ann Arbor, Michigan
The University of Maryland Genomics Center (ends 2025)
Principal Investigator/Director: David Rasko, Ph.D.
Institute: The University of Maryland, Baltimore, Maryland